Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-06-19

General Principles of Antimicrobial Therapy

Selection, PK/PD, Combinations, Resistance, Prophylaxis & Stewardship

Past RGUHS + DNB + MPMSU + MUHS + VNSGU · 10 VNSGUJan '25 RGUHSJun '24 RGUHSNov '22 DNBJun '21 MPMSU2018 MUHSSummer '18 RGUHSNov '16 RGUHSMay '11 RGUHSOct '10 RGUHSMay '10

Introduction & definitions

  • Chemotherapy = treatment of systemic infection with drugs that selectively suppress/kill the pathogen without significantly harming the host; the property exploited is selective microbial toxicity — action on a target absent in the host (cell wall, folate synthesis) or higher affinity for a microbial molecule (trimethoprim for bacterial DHFR).
  • Antibiotic (strict sense) = a substance produced by a microorganism that suppresses/kills other microbes at very low concentration; antimicrobial agent (AMA) is the preferred umbrella term covering synthetic + naturally derived agents (antibacterial, antiviral, antifungal, antiparasitic).
  • Antimicrobials are best viewed as ligands whose receptors are essential microbial proteins (Ehrlich's pharmacophore); processes inhibited include cell-wall/membrane synthesis, ribosomal translation, nucleic-acid metabolism, topoisomerases, folate synthesis, and viral proteases/integrases.
  • Bacteriostatic vs bactericidal — cell-wall-active agents (β-lactams, vancomycin) and aminoglycosides/fluoroquinolones/rifampin/metronidazole are generally cidal; protein-synthesis inhibitors (tetracyclines, chloramphenicol, macrolides, clindamycin, linezolid) and sulfonamides are generally static. The distinction is conditional (static drugs may be cidal at high concentration/in urine).
Continue reading

General Antimicrobial Therapy

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.